Renalytix Ai Stock Performance
| RNLX Stock | USD 0.46 0.01 2.87% |
The company holds a Beta of -0.28, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Renalytix are expected to decrease at a much lower rate. During the bear market, Renalytix is likely to outperform the market. At this point, Renalytix AI has a negative expected return of -1.18%. Please make sure to check Renalytix's total risk alpha, daily balance of power, as well as the relationship between the Daily Balance Of Power and relative strength index , to decide if Renalytix AI performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Renalytix AI has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in July 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
1 | KidneyIntelX included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease | 03/14/2024 |
2 | Discretionary transaction by Mills Christopher of tradable shares of Renalytix subject to Rule 16b-3 | 03/25/2024 |
3 | Renalytix Announces Financing with Expected Size of up to 4 Million | 04/08/2024 |
4 | Renalytix files to sell 19.99M ordinary shares for holders | 04/17/2024 |
5 | Renalytix AI Announces Fundraising, Executive Changes, and Shareholder Approval - TipRanks.com - TipRanks | 04/23/2024 |
6 | Acquisition by Icahn School Of Medicine At Mount Sinai of 9360374 shares of Renalytix at 0.25 subject to Rule 16b-3 | 04/24/2024 |
7 | Renalytix AI Plc Expands Share Offerings - TipRanks.com - TipRanks | 04/29/2024 |
8 | Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15 | 05/09/2024 |
9 | Renalytix AI shares target cut, maintains buy rating | 05/16/2024 |
10 | Renalytix AI PLC Sponsored ADR Loses -44.61 percent in 4 Weeks, Heres Why a Trend Reversal May be Around ... - Yahoo Movies UK | 05/29/2024 |
| Begin Period Cash Flow | 41.3 M |
Renalytix |
Renalytix Relative Risk vs. Return Landscape
If you would invest 117.00 in Renalytix AI on March 7, 2024 and sell it today you would lose (70.71) from holding Renalytix AI or give up 60.44% of portfolio value over 90 days. Renalytix AI is currently does not generate positive expected returns and assumes 7.5172% risk (volatility on return distribution) over the 90 days horizon. In different words, 66% of stocks are less volatile than Renalytix, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Renalytix Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Renalytix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Renalytix AI, and traders can use it to determine the average amount a Renalytix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.157
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RNLX |
Estimated Market Risk
| 7.52 actual daily | 66 66% of assets are less volatile |
Expected Return
| -1.18 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Renalytix is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Renalytix by adding Renalytix to a well-diversified portfolio.
Renalytix Fundamentals Growth
Renalytix Stock prices reflect investors' perceptions of the future prospects and financial health of Renalytix, and Renalytix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Renalytix Stock performance.
| Return On Equity | -10.73 | ||||
| Return On Asset | -0.86 | ||||
| Operating Margin | (11.47) % | ||||
| Current Valuation | 71.66 M | ||||
| Shares Outstanding | 77.18 M | ||||
| Price To Book | 20.68 X | ||||
| Price To Sales | 22.89 X | ||||
| Revenue | 3.4 M | ||||
| Gross Profit | 720 K | ||||
| EBITDA | (35.5 M) | ||||
| Net Income | (46.22 M) | ||||
| Cash And Equivalents | 32.36 M | ||||
| Cash Per Share | 0.89 X | ||||
| Total Debt | 12.15 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 2.48 X | ||||
| Book Value Per Share | (0.09) X | ||||
| Cash Flow From Operations | (32.67 M) | ||||
| Earnings Per Share | (0.76) X | ||||
| Market Capitalization | 33.47 M | ||||
| Total Asset | 42.12 M | ||||
| Retained Earnings | (99.18 M) | ||||
| Working Capital | 12.2 M | ||||
About Renalytix Performance
To evaluate Renalytix AI Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Renalytix generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Renalytix Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Renalytix AI market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Renalytix's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 111.54 | 105.96 | |
| Return On Tangible Assets | (1.80) | (1.71) | |
| Return On Capital Employed | (1.87) | (1.78) | |
| Return On Assets | (1.26) | (1.20) | |
| Return On Equity | (2.88) | (2.74) |
Things to note about Renalytix AI performance evaluation
Checking the ongoing alerts about Renalytix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Renalytix AI help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Renalytix AI generated a negative expected return over the last 90 days | |
| Renalytix AI has high historical volatility and very poor performance | |
| Renalytix AI has some characteristics of a very speculative penny stock | |
| Renalytix AI has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 3.4 M. Net Loss for the year was (46.22 M) with profit before overhead, payroll, taxes, and interest of 720 K. | |
| Renalytix AI currently holds about 32.36 M in cash with (32.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.89, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Renalytix AI has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Renalytix AI PLC Sponsored ADR Loses -44.61 percent in 4 Weeks, Heres Why a Trend Reversal May be Around ... - Yahoo Movies UK |
- Analyzing Renalytix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Renalytix's stock is overvalued or undervalued compared to its peers.
- Examining Renalytix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Renalytix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Renalytix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Renalytix's stock. These opinions can provide insight into Renalytix's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Renalytix Stock Analysis
When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.